Abstract

Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers

Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 508-513

Download in electronic PDF format for $75

Abstract

As a required service of the Medicare Modernization Act of 2003, medication therapy management services must be offered by all Part D prescription drug-plan sponsors in order to improve overall knowledge of medication usage for targeted patients. Those targeted patients include patients who have multiple chronic diseases, have been prescribed several covered Part D medications, and are paying at least $4,000 for their medication each year. This article discusses some of the barriers and recommendations to overcome such barriers encountered by Indiana pharmacists.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2008 Pg. 508-513	Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008 Pg. 414-418	Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Jul/Aug 2008 Pg. 329-333	Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Jan/Feb 2003 Pg. 42-43	Technology Spotlight: Barrier Isolators Author(s): Moussa Magdy, Rahe Hank, Lo Katharine
Jul/Aug 2001 Pg. 254-258	Sterile Compounding with Barrier-Isolation Technology Author(s): Rahe Hank
Sep/Oct 2010 Pg. 382-394	Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Author(s): Meadows Richard L, Muller George
Nov/Dec 2010 Pg. 450-455	Home Infusion: Overcoming the Barriers to Entry Author(s): Franklin David M
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 526-530	Barrier Isolator/Glovebox Glove Dexterity Study Author(s): Park Young H, Pines E, Cournoyer M E
Jul/Aug 2015 Pg. 315-320	Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Author(s): Akers Michael J
Nov/Dec 2001 Pg. 422-423	Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Author(s): Karolchyk Scott
Mar/Apr 2006 Pg. 128-133	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 Author(s): Wagner James T
May/Jun 2006 Pg. 208-211	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Author(s): Wagner James T
Jul/Aug 2007 Pg. 338-346	Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Author(s): Park Young H, Pines E, Ofouku M, Cournoyer ME
Jan/Feb 2007 Pg. 56-58	Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Author(s): Anderson Derick
May/Jun 2005 Pg. 201-205	Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Author(s): Harrington Catherine A, Cauffield Jacintha
Jan/Feb 2005 Pg. 53-56	Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Author(s): Rahe Hank
Sep/Oct 2005 Pg. 407-408	PostScription: Searching for Barrier Isolator Information? Author(s): Fink Carl, Newman John
Mar/Apr 2002 Pg. 142-146	Bioidentical Hormone Replacement Therapy, Part 3, A Review of Author(s): Wepfer Scott T